Compugen Gross Profit vs Ebitda Analysis
CGEN Stock | USD 1.60 0.03 1.84% |
Compugen financial indicator trend analysis is way more than just evaluating Compugen prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Compugen is a good investment. Please check the relationship between Compugen Gross Profit and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
Gross Profit vs Ebitda
Gross Profit vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Compugen Gross Profit account and Ebitda. At this time, the significance of the direction appears to have weak relationship.
The correlation between Compugen's Gross Profit and Ebitda is 0.35. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Ebitda in the same time period over historical financial statements of Compugen, assuming nothing else is changed. The correlation between historical values of Compugen's Gross Profit and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Compugen are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Gross Profit i.e., Compugen's Gross Profit and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.35 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Compugen minus its cost of goods sold. It is profit before Compugen operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Ebitda
Most indicators from Compugen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Compugen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.As of the 11th of December 2024, Tax Provision is likely to grow to about 9.4 M, while Selling General Administrative is likely to drop about 6.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Net Interest Income | 871K | 1.7M | 3.2M | 3.4M | Interest Income | 894K | 1.7M | 3.0M | 3.1M |
Compugen fundamental ratios Correlations
Click cells to compare fundamentals
Compugen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Compugen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 53.8M | 138.3M | 132.2M | 94.2M | 121.3M | 70.8M | |
Other Current Liab | 4.4M | 7.8M | 10.9M | 8.9M | 11.0M | 11.5M | |
Total Current Liabilities | 6.8M | 10.5M | 17.1M | 11.9M | 26.3M | 27.6M | |
Total Stockholder Equity | 38.3M | 119.8M | 106.7M | 77.7M | 65.6M | 57.7M | |
Property Plant And Equipment Net | 5.6M | 4.5M | 3.9M | 3.4M | 2.5M | 3.3M | |
Net Debt | (40.3M) | (4.0M) | (5.1M) | (9.1M) | (12.5M) | (13.2M) | |
Retained Earnings | (358.2M) | (387.9M) | (422.1M) | (455.8M) | (474.5M) | (450.8M) | |
Accounts Payable | 1.1M | 1.4M | 4.6M | 1.8M | 3.5M | 1.9M | |
Cash | 43.9M | 7.1M | 7.8M | 11.1M | 13.9M | 26.5M | |
Non Current Assets Total | 8.8M | 9.2M | 8.9M | 8.1M | 6.8M | 10.6M | |
Non Currrent Assets Other | 3.2M | 4.7M | 5.0M | 4.7M | 4.2M | 3.9M | |
Cash And Short Term Investments | 43.9M | 124.4M | 117.8M | 83.7M | 50.7M | 48.3M | |
Net Receivables | 1.1M | 2.2M | 188K | 317K | 61.3M | 64.4M | |
Common Stock Shares Outstanding | 63.6M | 79.6M | 84.2M | 86.6M | 87.6M | 47.3M | |
Liabilities And Stockholders Equity | 53.8M | 138.3M | 132.2M | 94.2M | 121.3M | 70.8M | |
Non Current Liabilities Total | 8.6M | 8.0M | 8.4M | 4.6M | 29.5M | 31.0M | |
Inventory | (780K) | (119.3M) | (110.0M) | (72.6M) | (65.4M) | (62.1M) | |
Other Stockholder Equity | 396.3M | 507.4M | 528.5M | 533.2M | 539.8M | 292.4M | |
Total Liab | 15.4M | 18.5M | 25.5M | 16.5M | 55.8M | 58.6M | |
Property Plant And Equipment Gross | 5.6M | 4.5M | 3.9M | 3.4M | 7.9M | 8.3M | |
Total Current Assets | 45M | 129.1M | 123.2M | 86.1M | 114.6M | 120.3M | |
Accumulated Other Comprehensive Income | (6.3M) | (4.9M) | (5.4M) | 2K | 2.3K | 2.4K | |
Common Stock | 187K | 231K | 239K | 240K | 247K | 133.4K | |
Other Liab | 5.6M | 5.5M | 6.4M | 3.3M | 3.8M | 4.6M | |
Other Assets | 3.2M | 4.7M | 5.0M | 4.7M | 5.4M | 5.7M | |
Short Term Investments | 34.0M | 116.6M | 109.2M | 72.3M | 36.8M | 29.0M | |
Other Current Assets | 780K | 2.5M | 5.3M | 2.1M | 2.6M | 4.9M | |
Property Plant Equipment | 5.6M | 4.5M | 3.9M | 3.4M | 3.9M | 3.4M | |
Net Tangible Assets | 38.3M | 119.8M | 106.7M | 77.7M | 89.3M | 77.0M | |
Net Invested Capital | 38.3M | 119.8M | 106.7M | 77.7M | 65.6M | 74.6M | |
Net Working Capital | 38.2M | 118.6M | 106.1M | 74.2M | 88.3M | 76.5M | |
Capital Stock | 187K | 231K | 239K | 240K | 247K | 239.8K |
Pair Trading with Compugen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.Moving together with Compugen Stock
Moving against Compugen Stock
0.81 | BMY | Bristol Myers Squibb | PairCorr |
0.57 | ESPR | Esperion Therapeutics | PairCorr |
0.57 | IKT | Inhibikase Therapeutics | PairCorr |
0.51 | XCUR | Exicure Upward Rally | PairCorr |
0.48 | DYAI | Dyadic International | PairCorr |
The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.
The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 | Revenue Per Share 0.48 | Quarterly Revenue Growth 3.461 | Return On Assets (0.03) | Return On Equity (0.16) |
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.